A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...

Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...

Amsbio now offers a ready-to-use range of lentiviral particles designed to deliver target genes into virtually any mammalian cell type, both dividing and non-dividing, in vitro and in vivo. These ...